Migraine, Hemicrania

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Migraine, Hemicrania trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT04930887

Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain

Exparel has a proven efficacy in providing pain relief for up to 72 hours with a single-dose administration at surgical sites. The study aims to evaluate the ef…

United States15 participantsStarted 2023-02-01

Treatment: Exparel (Bupivacaine Liposome), Saline

All recent trials (5 shown)

TerminatedNot Applicable

NCT06200480

Nurse Intervention Trial

This randomized open-label prospective study focus on headache patients initiating preventive treatment, where the treating physician identifies a need for foll…

Norway147 participantsStarted 2023-04-21

Treatment: Telephone by nurse

By InvitationPhase 1

NCT03511846

Pain Biomarker Study

This study investigates molecular and physical biomarkers of headaches in order to better understand mechanisms of these diseases. There are 3 main parts: 1.…

United States371 participantsStarted 2018-03-21

Treatment: Oral capsaicin, Topical capsaicin

Migraine, Hemicrania

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain

All recent trials (5 shown)

Nurse Intervention Trial

Pain Biomarker Study

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain

All recent trials (5 shown)

Nurse Intervention Trial

Pain Biomarker Study

Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency

Acupuncture for Migraine Prophylaxis